Calcium chloride
- Generic Name
- Calcium chloride
- Brand Names
- Artiss, Bss, Bss Ophthalmic Solution, Calciject, Cardioplegic, Citrasate, Clinimix E 2.75/5, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, H.E.L.P.bicel, Hemosate Ultra, Hyperlyte, Lactated Ringers, Naturalyte, Nxstage Pureflow, Olimel, Periolimel, Phoxillum, Physioneal 40, Plasma-lyte R, Plegisol, Prismasol, Ringers, Selectbag One, Tisseel
- Drug Type
- Small Molecule
- Chemical Formula
- CaCl2
- CAS Number
- 10043-52-4
- Unique Ingredient Identifier
- OFM21057LP
- Background
Calcium chloride is an ionic compound of calcium and chlorine. It is highly soluble in water and it is deliquescent. It is a salt that is solid at room temperature, and it behaves as a typical ionic halide. It has several common applications such as brine for refrigeration plants, ice and dust control on roads, and in cement. It can be produced directly from...
- Indication
For the treatment of hypocalcemia in those conditions requiring a prompt increase in blood plasma calcium levels, for the treatment of magnesium intoxication due to overdosage of magnesium sulfate, and used to combat the deleterious effects of hyperkalemia as measured by electrocardiographic (ECG), pending correction of the increased potassium level in the e...
- Associated Conditions
- Acute Renal Failure (ARF), Dehydration, Dehydration Hypertonic, Dry Mouth, Electrolyte depletion, End-stage Chronic Kidney Failure, Fluid Loss, Hyperkalemia, Hypocalcemia, Hypocalcemic tetany, Hypovolaemia, Isotonic Dehydration, Renal Failure, Chronic Renal Failure, Shock, Hypovolemic, Beta blocker overdose, Calcium channel blocker overdose
- Associated Therapies
- Continuous Renal Replacement Therapy, Electrolyte replacement, Haemodiafiltration, Haemofiltration, Hemodialysis Treatment, Irrigation therapy, Parenteral Nutrition, Peritoneal dialysis therapy, Plasma Volume Replacement, Urine alkalinization therapy, Distension of the joints, Extraocular irrigation, Fluid and electrolyte maintenance therapy, Induction of cardiac arrest, Irrigation of the joints
A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2017-05-22
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT00955266
- Locations
- 🇺🇸
Brigham and Womens Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.